Saleh's technique: injecting Histoacryl glue into the pancreas during pancreaticojejunostomy
Official title: Pancreatic Parenchymal Injection of N-Butyl-2-Cyanoacrylate for Pancreaticojejunostomy After Pancreaticoduodenectomy: A Novel Technique
Run by Minia University · NCT07132541 · Data updated 2026-11-12
This procedure will try injecting a tissue glue (Histoacryl) into the pancreas during pancreaticoduodenectomy to see if it reduces pancreatic leaks in people with a soft pancreas and a small pancreatic duct.
Quick facts
| Phase | Phase 1 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Minia University Academic / other |
| Locations | 1 site (Minya, Minya Governorate) |
| Status | Recruiting |
| Started | August 25, 2025 |
| Main results expected | November 25, 2026 |
| Study ends | December 25, 2026 |
| Registry record updated | September 11, 2026 |
| Trial ID | NCT07132541 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients planned for pancreaticoduodenectomy for curative-intent malignancy who have a soft pancreatic texture, a main pancreatic duct diameter under 3 mm, and can provide informed consent.
✕Probably not a fit
Patients with a hard or fibrotic pancreas, large pancreatic ducts, active infection, uncontrolled coagulopathy, distant metastases, or who are unfit for surgery are not candidates and are unlikely to benefit from this technique.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This Phase 1 interventional study injects N-butyl-2-cyanoacrylate (Histoacryl) into the pancreatic parenchyma at the time of pancreaticojejunostomy in patients undergoing pancreaticoduodenectomy who have a soft pancreas and a main duct under 3 mm. Thirty consecutive patients having curative-intent resection for pancreatic, periampullary, cholangiocarcinoma, or duodenal cancer will be enrolled at Minia University between July 2025 and July 2026. The trial's primary focus is safety and feasibility, with systematic collection of preoperative, intraoperative, and postoperative data and monitoring for clinically relevant postoperative pancreatic fistula (POPF) and other complications. Secondary observations include preservation of exocrine drainage, technical performance of parenchymal injection, and rates of parenchymal leakage.
Why it matters
Potential benefit: If successful, the technique could lower clinically significant postoperative pancreatic fistula rates and the complications that follow after pancreaticoduodenectomy.
How similar studies have gone: Use of cyanoacrylate and other tissue adhesives to reinforce pancreatic anastomoses is relatively novel with only limited case series and no large randomized trials demonstrating clear benefit to date.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients undergoing pancreaticoduodenectomy for malignant lesions meeting the curative treatment intent in accordance with clinical guidelines. * Soft pancreatic texture. * Small main pancreatic duct diameter (\<3 mm). * Informed consent obtained. Exclusion Criteria: * Known hypersensitivity to cyanoacrylate or Lipiodol®. * Extremely hard, fibrotic pancreas. * Significant pancreatitis involving the pancreatic remnant. * Active infection at the surgical site. * Uncontrolled coagulopathy. * Unfit patients for surgery due to severe medical illness. * Inoperable patients with distant metastases, including peritoneal, liver, distant lymph node metastases, and involvement of other organs. * Irresectable tumors in diagnostic laparoscopy. * Patients requiring left, central or total pancreatectomy or other palliative surgery. * Pregnant or breastfeeding women. * Patients with serious mental disorders. * Patients with vascular invasion and requiring vascular resection. * Patients refused to participate in the study.
Where it's running
-
Liver and GIT hospital , Minia University
Minya, Minya Governorate, Egypt Recruiting
Study contacts
- Principal investigator: Saleh K Saleh, MD — Minia University
- Study coordinator: Saleh K Saleh, MD
- Email: salehkhairy@mu.edu.eg
- Phone: 01201765401
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tissue-glue injection into the pancreas during pancreaticoduodenectomy
This trial will test whether injecting a tissue glue called N-butyl-2-cyanoacrylate into the pancreatic remnant during pancreaticoduodenectomy reduces postoperative pancreatic fistulas in patients with a soft pancreas and a small main duct.
-
Neoadjuvant chemotherapy versus immediate surgery for resectable pancreatic head and periampullary cancer
This trial tests if giving chemotherapy before surgery helps people with resectable pancreatic head or periampullary cancer live longer than having immediate surgery followed by chemotherapy.
-
Predicting pancreatic fistula after pancreaticoduodenectomy
This project will try to find which before-, during-, and after-surgery factors predict clinically significant pancreatic fistula in adults having pancreaticoduodenectomy for pancreatic or periampullary tumors.
-
Surgery with Islet Autotransplantation for Patients with Pancreatic Cancer
This study is testing if a surgery that includes removing the whole pancreas and transplanting the patient's own insulin-producing cells can help people with pancreatic cancer avoid complications and start treatment faster compared to just removing part of the pancreas.
-
Analyzing factors affecting pancreatic tumors and cysts
This study looks at how different factors affect pancreatic tumors and cysts to help improve treatment options for patients.
-
Local complications of acute pancreatitis and postoperative pancreatic fistula: what happens in real life
This multicenter registry tests how local pancreatic complications are managed in routine care and what outcomes look like over 180 days for adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.